Skip to main content

Legume intake and risk of nonalcoholic fatty liver disease

Abstract

Background

It is known that diet plays a pivotal role in the pathogenesis and management of nonalcoholic fatty liver disease (NAFLD); however, the knowledge on the role of different food groups such as legumes is not enough.

Methods

We designed this study to assess the relationship between legume intake and risk of NAFLD in framework of a case-control study among Tehrani adults. One hundred and ninety-six newly diagnosed patients with NAFLD and 803 controls were studied, and their dietary intake was assessed using a valid and reliable food frequency questionnaire. Conditional logistic regression was used to determine the odds ratio (OR) of NAFLD per increase of one serving/week dietary legumes, lentil, and beans adjusting for potential confounders.

Results

In energy-adjusted model, greater intake of legumes, lentils, and beans was associated with a lower risk of NAFLD. These risk associations remained significant after adjusting for all known risk factors of NAFLD. OR of NAFLD in adjusted models for higher dietary intake of legumes, lentils, and beans were 0.73 (0.64–0.84), 0.61 (0.46–0.78), and 0.35 (0.17–0.74), respectively.

Conclusion

Our findings suggest that higher intake of total legumes (beans, lentils, and peas) was associated with lower risk of NAFLD.

This is a preview of subscription content, access via your institution.

References

  1. Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic fatty liver disease, the gut microbiome, and diet. Adv Nutr. 2017;8:240–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Duseja A, Singh SP, Saraswat VA et al. Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5:51–68.

  3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664–9.

    Article  CAS  PubMed  Google Scholar 

  4. Kanuri G, Bergheim I. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci. 2013;14:11963–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28:339-50.

  6. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia—as common and important as in the west. Nat Rev Gastroenterol Hepatol. 2013;10:307–18.

    Article  CAS  PubMed  Google Scholar 

  7. Moghaddasifar I, Lankarani K, Moosazadeh M, et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplant Med. 2016;7:149–60.

  8. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52.

    Article  PubMed  Google Scholar 

  9. Valenti L, Dongiovanni P, Piperno A, et al. α1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology. 2006;44:857–64.

  10. Ghaemi A, Taleban FA, Hekmatdoost A, et al. How much weight loss is effective on nonalcoholic fatty liver disease? Hepat Mon. 2013;13:e15227.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.

    Article  PubMed  Google Scholar 

  12. Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 2016;67:1024–9.

    Article  CAS  PubMed  Google Scholar 

  13. Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study. Int J Food Sci Nutr. 2016;67:461–9.

    Article  CAS  PubMed  Google Scholar 

  14. Emamat H, Foroughi F, Eini-Zinab H, Taghizadeh M, Rismanchi M, Hekmatdoost A. The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. J Diabetes Metab Disord. 2016;15:25.

  15. Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99:535–42.

    Article  CAS  PubMed  Google Scholar 

  16. Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz SA. Ginger supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Hepat Mon. 2016;16:e34897.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Trinidad TP, Mallillin AC, Loyola AS, Sagum RS, Encabo RR. The potential health benefits of legumes as a good source of dietary fibre. Br J Nutr. 2010;103:569–74.

    Article  CAS  PubMed  Google Scholar 

  18. Bazzano L, He J, Ogden L, et al. Legume consumption and risk of coronary heart disease in US men and women. NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:2573–8.

    Article  CAS  PubMed  Google Scholar 

  19. Papanikolaou Y, Fulgoni VL 3rd. Bean consumption is associated with greater nutrient intake, reduced systolic blood pressure, lower body weight, and a smaller waist circumference in adults: results from the National Health and Nutrition Examination Survey 1999-2002. J Am Coll Nutr. 2008;27:569–76.

  20. Bazzano LA, Thompson AM, Tees MT, Nguyen CH, Winham DM. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2011;21:94–103.

    Article  CAS  PubMed  Google Scholar 

  21. Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A. Egg consumption and risk of non-alcoholic fatty liver disease. World J Hepatol. 2017;9:503–9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13:654–62.

    Article  PubMed  Google Scholar 

  23. Food and Nutrition Information Center, US Department of Agriculture: Food composition table (FCT). Beltsville, MD. 2009. www.nal.usda.gov/fnic/foodcomp. Accessed 27 June 2011.

  24. Azizi F. Legume intake is inversely associated with metabolic syndrome in adults. Arch Iran Med. 2012;15:538–44.

    PubMed  Google Scholar 

  25. Becerra-Tomás N, Díaz-López A, Rosique-Esteban N, et al. Legume consumption is inversely associated with type 2 diabetes incidence in adults: a prospective assessment from the PREDIMED study. Clin Nutr. 2017;37:906–13.

    Article  PubMed  Google Scholar 

  26. Kang R, Kim M, Chae JS, Lee S-H, Lee JH. Consumption of whole grains and legumes modulates the genetic effect of the APOA5-1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Trials. 2014;15:100.

  27. Kim S, Hong J, Jeon R, Kim H-S. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Nutr Res. 2016;36:90–100.

    Article  CAS  PubMed  Google Scholar 

  28. Ferolla SM, Ferrari TC, Lima ML, et al. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo). 2013;68:11–7.

  29. Guillon F, Champ M-J. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr. 2002;88:293–306.

    Article  CAS  Google Scholar 

  30. Duranti M. Grain legume proteins and nutraceutical properties. Fitoterapia. 2006;77:67–82.

    Article  CAS  PubMed  Google Scholar 

  31. Thorne MJ, Thompson L, Jenkins D. Factors affecting starch digestibility and the glycemic response with special reference to legumes. Am J Clin Nutr. 1983;38:481–8.

    Article  CAS  PubMed  Google Scholar 

  32. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.

    Article  CAS  PubMed  Google Scholar 

  33. Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr. 2006;83:89–94.

    Article  CAS  PubMed  Google Scholar 

  34. Holt SH, Miller JB. Increased insulin responses to ingested foods are associated with lessened satiety. Appetite. 1995;24:43–54.

    Article  CAS  PubMed  Google Scholar 

  35. Anderson GH, Woodend D. Effect of glycemic carbohydrates on short-term satiety and food intake. Nutr Rev. 2003;61 Suppl-5:S17–26.

  36. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Rebello C, Greenway F, Finley JW. A review of the nutritional value of legumes and their effects on obesity and its related co-morbidities. Obes Rev. 2014;15:392–407.

    Article  CAS  PubMed  Google Scholar 

  38. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.

    Article  CAS  PubMed  Google Scholar 

  39. Chatterjee R, Yeh H-C, Edelman D, Brancati F. Potassium and risk of type 2 diabetes. Expert Rev Endocrinol Metab. 2011;6:665–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Dong J-Y, Xun P, He K, Qin L-Q. Magnesium intake and risk of type 2 diabetes. Diabetes Care. 2011;34:2116–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Villegas R, Gao Y-T, Yang G, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women’s Health Study. Am J Clin Nutr. 2008;87:162–7.

  42. Sievenpiper JL, Kendall CW, Esfahani A, et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia. 2009;52:1479–95.

  43. Zhang Z, Lanza E, Kris-Etherton PM, et al. A high legume low glycemic index diet improves serum lipid profiles in men. Lipids. 2010;45:765–75.

  44. Birketvedt GS, Travis A, Langbakk B, Florholmen JR. Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects. Nutrition. 2002;18:729–33.

    Article  CAS  PubMed  Google Scholar 

  45. Macarulla MT, Medina C, De Diego MA, et al. Effects of the whole seed and a protein isolate of faba bean (Vicia faba) on the cholesterol metabolism of hypercholesterolaemic rats. Br J Nutr. 2001;85:607–14.

    Article  CAS  PubMed  Google Scholar 

  46. Finley JW, Burrell JB, Reeves PG. Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. J Nutr. 2007;137:2391–8.

    Article  CAS  PubMed  Google Scholar 

  47. Willett W. Nutritional Epidemiology. New York: Oxford University Press; 2012.

    Book  Google Scholar 

Download references

Acknowledgments

This study is related to the project NO. 1396/114499 From Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

The “Student Research Committee” and “Research and Technology Chancellor” in Shahid Beheshti University of Medical Sciences financially supported this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Azita Hekmatdoost.

Ethics declarations

Conflict of interest

AB, FT, TE, GS, EH, HP, and AH declare that they have no conflict of interest.

Ethics statement

The authors declare that the study was performed in a manner conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer. com. The study was approved by the ethics committee of National Nutrition and Food Technology Research Institute, Tehran, Iran.

Disclaimer

The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, or the printer/publishers are responsible for the results/findings and content of this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bahrami, A., Teymoori, F., Eslamparast, T. et al. Legume intake and risk of nonalcoholic fatty liver disease. Indian J Gastroenterol 38, 55–60 (2019). https://doi.org/10.1007/s12664-019-00937-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-019-00937-8

Keywords

  • Bean
  • Legumes
  • Lentil
  • Nonalcoholic fatty liver disease